SPONSOR
National Institute of Neurological Disorders and Stroke (NINDS)
Total Trials
9
Recruiting
9
Phases
Phase 1, Phase 2, EARLY_Phase 1, Phase 1, Phase 2
Conditions studied: Progressive Multifocal LeukoencephalopathyAmyotrophic Lateral SclerosisMotor Neuron DiseaseMultiple SclerosisFatigue Syndrome, ChronicRecurrent GlioblastomaGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeRelapsed CancerRecurrent TumorGlioblastoma Multiforme
National Institute of Neurological Disorders and Stroke (NINDS) is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Progressive Multifocal Leukoencephalopathy, Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Multiple Sclerosis.
The trial portfolio spans Phase 1, Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Institute of Neurological Disorders and Stroke (NINDS)
How many clinical trials has National Institute of Neurological Disorders and Stroke (NINDS) sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by National Institute of Neurological Disorders and Stroke (NINDS), of which 9 are actively recruiting participants. These trials cover conditions including Progressive Multifocal Leukoencephalopathy, Amyotrophic Lateral Sclerosis, Motor Neuron Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Institute of Neurological Disorders and Stroke (NINDS) research focus on?
National Institute of Neurological Disorders and Stroke (NINDS) clinical trials span Progressive Multifocal Leukoencephalopathy, Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Multiple Sclerosis, Fatigue Syndrome, Chronic, and additional conditions. The research pipeline includes Phase 1, Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Institute of Neurological Disorders and Stroke (NINDS) clinical trial?
To participate in a National Institute of Neurological Disorders and Stroke (NINDS) trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Institute of Neurological Disorders and Stroke (NINDS) trials with current recruitment status updated daily.
Clinical Trials by National Institute of Neurological Disorders and Stroke (NINDS)
NCT01730131
Recruiting
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Progressive Multifocal Leukoencephalopathy
NCT07204977 Phase 1
Recruiting
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
Amyotrophic Lateral Sclerosis
NCT02784210 Phase 2
Recruiting
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
Multiple Sclerosis
NCT06472622 EARLY_Phase 1
Recruiting
Functional Neuroimaging to Detect the Neural Signatures of the Unpleasantness of Pain and Effort
Fatigue Syndrome, Chronic
NCT00001248
Recruiting
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Multiple Sclerosis
NCT07416188 Phase 1, Phase 2
Recruiting
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Recurrent Glioblastoma
NCT05413291
Recruiting
Natural History Protocol for Movement Disorders
Movement Disorder
NCT06630650
Recruiting
A Prospective Natural History and Outcome Measure Validation Study of Congenital Myasthenic Syndromes
Myasthenic Syndromes, Congenital
NCT03288220
Recruiting
Influence of Brain Oscillation-Dependent TMS on Motor Function
Healthy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology